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Abstract
Background: Ketamine, as an opium alternative, has been proposed for pain relief in the emergency department (ED).
Objectives: This study was carried out to compare low dose ketamine (LDK) with morphine for pain relief in trauma patients.
Methods: In this randomized double-blinded clinical trial, 300 trauma patients from the ED of 2 teaching hospitals in Tehran, Iran
were enrolled and randomly divided into 2 equal groups. The 1st group received 0.2 mg/kg of ketamine while the 2nd group received
0.1 mg/kg of intravenous morphine. The pain intensity and complications were measured and compared every 15 minutes to 1 hour.
Results: Fifteen minutes after drug injection in both groups, a significant reduction was found in average pain intensity compared
to the initial pain (P = 0.01). At 15 minutes, no significant difference was found in both groups in regards to average pain intensity (P
= 0.23). The average pain intensity at 30, 45, and 60 minutes in the group receiving morphine was lower than the ketamine group
(P = 0.01, P < 0.001, P < 0.001 respectively). Two complications (drop in O2 saturation below 90% and flushing) were significantly
greater in the morphine group.
Conclusions: The results of this study suggest that LDK, at a dose of 0.2 mg/kg, in the earlier minutes leads to significant reduction
of pain when compared to that of intravenous morphine. It also created fewer complications than morphine.
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1. Background
Pain is one of the most common symptoms in patients
in the emergency departments (EDs) (1, 2). Furthermore,
effective pain reduction increases the patient satisfaction
and prevents delayed physical and mental complications
such as persistent pain syndrome and pain related anxiety
as well as distress (3, 4).
Intravenous opium (morphine) is the most common
medication used to decrease pain in the EDs (5-7). De-
spite the analgesic benefits and availability of morphine,
it has some complications such as over sedation and res-
piratory depression (8). On the other hand, usual dose of
0.1 mg/kg of morphine cannot suppress the severe pain
of many patients in EDs (9). Ketamine is an N-methyl-D-
aspartate (NMDA) receptor antagonist, which has been uti-
lized since 1970s for anesthesia (10). Due to the rapid onset
and the absence of significant respiratory complications,
it has been taken into consideration in EDs for procedural
sedation analgesia and pain management (11, 12).
Low dose ketamine (LDK), by definition, is applied to
doses less than 1 mg/kg (13). From several studies, it has
been demonstrated that the addition of LDK to morphine
reduced the dose of morphine and its complications (14,
15). Few studies have been carried out to investigate the
analgesic effect of ketamine as a single agent in EDs. To the
best of our knowledge, this is the first study that compared
intravenous LDK at a dose of 0.2 mg/kg with morphine in
trauma patients with a large sample size.
2. Objectives
In this study, we compared the analgesic effect of ke-
tamine at a dose of 0.2 mg/kg with intravenous morphine
at a dose of 0.1 mg/kg and the secondary outcome was to
compare the side effects of these medications.
3. Methods
3.1. Study Designs and Participants
This randomized double-blinded clinical trial was car-
ried out to compare the efficacy and safety of intravenous
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LDK with intravenous morphine for pain management of
trauma patients in the emergency departments of 2 uni-
versity teaching hospitals (Hazrat Rasool and Haftom Tir)
in Tehran, Iran from September 2014 to September 2015.
The study was approved by the Iranian registry of clinical
trials (IRCT2015111024979N1). The study included trauma
patients aged 18 to 70 years with a musculoskeletal pain
score of 5 or more on a standard 11-point (0 to 10) nu-
meric rating scale who were referred to the emergency
departments. The study protocol was approved by the
ethics committee of Iran University of Medical Sciences. Pa-
tients who met the following criteria were excluded from
the study: instability in vital signs, head trauma, Glas-
gow coma scale score less than 15, opiate users, psychi-
atric or cardiac problem, hypersensitivity to ketamine or
morphine, pregnancy, breast-feeding, renal or hepatic in-
sufficiency, and contraindications to use both medications
such as upper respiratory infections or hypersensitivity.
At first, consent forms containing detailed informa-
tion of the study were given to the patients and those who
declared their satisfaction in participation were included
to the study.
3.2. Study Instrument
Pain measurement was accomplished using a 10-cm
line with tick marks spaced 1 cm apart. The leftmost mark
is labeled “0” and means “no pain” and the rightmost mark
is labeled “10” and means “the worst pain imaginable”.
3.3. Intervention
Baseline pain score was determined with numeric rat-
ing scale. Patients with pain score of 5 or more were in-
cluded.
First, baseline characteristics and clinical data were
recorded according to the patients’ interview. Then, the
patients were randomly assigned (by block randomization
method) to 2 groups. The 1st group received 0.2 mg/kg of
ketamine and the 2nd group received 0.1 mg/kg of mor-
phine. Each syringe contained a clear colorless solution
of either 2 mg/mL ketamine or 1 mg/mL morphine. The
medication was injected intravenously by a nurse who was
blind to the study protocol. Sufficient pain reduction was
defined as a decrease in pain score equal to 3 or more (16).
In case of insufficient pain reduction, 3 milligrams of in-
travenous morphine was injected every 5 minutes as a res-
cue analgesic. Pain score, blood pressure, heart rate, pulse-
oxygen saturation, and drug side effects were assessed at 0,
15, 30, 45, and 60 minutes after drug administration. Nau-
sea was managed by antiemetic. Hypotension was consid-
ered present when the systolic blood pressure dropped to
90 mmHg and managed by bolus of fluid. Desaturation
was defined as an oxygen saturation of < 92% and man-
aged by head tilt-chin lift and bag- mask ventilation, as
needed. Bradycardia was mentioned when the heart rate
dropped to less than 60 per minute and managed by 0.5
mg intravenous atropine.
Patient satisfaction was asked 1 hour after drug injec-
tion by 5 points level of quality as excellent (point 5), very
good, good, fair, and poor. The answers of excellent and
very good were supposed as reaching proper analgesic ef-
fect.
3.4. Statistical Analysis
Data were analyzed by the SPSS 18 software. Results
were presented as mean± standard deviation for quanti-
tative variables. Pain scores were compared with indepen-
dent t-test to compare LDK and morphine groups. Paired t-
test was used to compare pain scores within groups. All of
categorical variables were analyzed by the chi-square test
except patient satisfaction, which was analyzed by Fisher’s
exact test. A P value of less than 0.05 was considered statis-
tically significant.
The sample size was calculated using the following for-
mula: n = 2 (Z1 -α + Z1 -β)
2 σ2 / d2. Effect size (d) and σ was
considered 3 and 9, respectively, based on the literature
review. Thus, the sample size in each group (LDK or mor-
phine) should be at least 142 patients. We enrolled 332 pa-
tients initially to cover the probable data loss.
4. Results
A total of 332 patients were enrolled in the study, how-
ever, 32 of them were excluded. All of the 300 patients were
randomly divided into 2 equal groups of LDK and mor-
phine. The patient flow diagram is shown in Figure 1. Pa-
tients’ demographic characteristics are shown in Table 1.
The patients’ mean ages were 34.4± 7.6 and 34.1± 7.3 years
in LDK and morphine groups, respectively. There was no
difference between the groups in terms of demographic
characteristics (except in weight) or vital signs and base-
line pain scores.
The mean dose of morphine and ketamine in each
group were 6.8± 1.2 mg and 14.9± 3.3 mg, respectively. A
total of 51 patients in the ketamine group and 15 patients
in the morphine group required an extra dose of the anal-
gesic (P = 0.01).
In both groups, 15 minutes after injection (T15), the
mean pain intensity when compared to the initial pain (T0)
had a statistically significant reduction (P = 0.01). More-
over, there was no significant difference between both
groups at baseline and T15 in terms of the mean pain in-
tensity. The mean pain intensity at 30, 45, and 60 minutes
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332 patients included 24 patients excluded 
12 refused to 
participate in the study 
7 Requested morphine 
only 
5 requested ketamine 
only 
308 patients analyzed 
Morphine group (n = 155) 
0.1 mg/kg morphine intravenously 
Ketamine group (n = 153) 
0.2 mg/kg ketamine intravenously  
Analyzed (n = 150) 
Excluded (n = 5) 
Incomplete data or disrespect 
the study protocol
Analyzed (n = 150) 
Excluded (n = 3) 
Incomplete data or disrespect 
the study protocol
Figure 1. Patients’ Flow Diagram
in the group receiving morphine was lower than the ke-
tamine group and the difference was statistically signifi-
cant (P = 0.01, P < 0.001, P < 0.001, respectively). In other
words, the analgesic effect of ketamine was reduced by
passing the time of injection (Table 2).
One hour after injection, when the sedation effect of
drugs has subsided, the patients’ satisfaction was evalu-
ated. A total of 114 patients of morphine group and 66 pa-
tients of ketamine group were satisfied with analgesic ef-
fect (P = 0.001).
No life-threatening complication was observed in both
groups. Complications include nausea, reduced O2 satura-
tion, dizziness, mood changes, and flushing; all complica-
tions were temporary and required no intervention other
than oxygenation with nasal cannula. A drop in O2 satura-
tion below 90% and flushing were significantly higher in
the morphine group (Table 3).
5. Discussion
The results of this study further illustrated that ke-
tamine, at a dose of 0.2 mg/kg 15 minutes after injection,
dramatically reduced the pain in trauma patients. When
compared with morphine, there was no statistically signif-
icant difference in T15.
Few studies have been carried out to investigate the
analgesic effect of pure ketamine in EDs. Ahern et al. (17)
carried out a retrospective case series study over 2 years
and examined the effects of ketamine in a variety of acute
and chronic pain in ED. Ketamine dose utilized was 0.1 to
0.3 mg/kg (5 to 25 mg IV or IM) alone or in combination
with other tranquilizer. Of the patients, 92% received 10 to
15 mg of Ketamine. A total of 6% of patients experienced
complications, most of them were non-significant. Finally,
it can be concluded that LDK is a safe and effective pain re-
lief in ED.
Majidinejad et al. (18) compared 0.5 mg/kg dose of ke-
tamine with 0.1 mg/kg of morphine in 126 emergency pa-
tients with long bone fracture. In this study, the reduction
of pain in the ketamine group, within 10 minutes after in-
jection, was significant, which was equivalent to morphine
group. The complication rate was also significantly higher
in the ketamine group.
Motov et al. (19) conducted a study on 90 ED patients
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Table 1. Patients’ Characteristics and Vital Signs
Variables Morphine Group, n = 150 Ketamine Group, n = 150 P Value
Age,mean (SD), y 34.1± 7.3 34.4± 7.6 0.93
Sex,male (%) 123 (82) 126 (84) 0.79
Weight, kg 68.4± 12.9 75.1± 14.6 0.018*
Final diagnosis, n (%)
Fracture 36 (24) 42 (28) 0.64
Soft tissue injury 114 (76) 108 (72) 0.68
Initial vital signs
SBP, mean (SD), (mm/Hg) 124.7± 12.3 123.2± 16.4 0.60
DBP, mean (SD), (mm/Hg) 82.2± 10.6 78.9± 13.7 0.17
Heart rate, mean (SD), (beats/min) 81± 9.5 79.2± 12.6 0.42
Oxygen saturation, mean (SD), (%) 97.1± 1.4 96.6± 2.3 0.17
Rescue analgesic, n (%) 15 (10) 51 (34) 0.001*
Patient satisfaction
T60 , n (%), excellent or good 114 (76) 66 (44) 0.001*
Abbreviations: NS, non-significant; SD, standard deviation; T60 , 60 minutes after drug injection.
Table 2. Pain Scores (Numeric Rating Scale)
Time (min) Group P Value
Ketamine Morphine
T0 8.1± 1.1 8.4± 0.9 0.15
T15 4.1± 2.8 4± 2.5 0.23
T30 4.5± 3.1 3.8± 3 0.01*
T45 4.8± 3.2 3.4± 3.1 < 0.001*
T60 4.9± 3.3 3.2± 2.9 < 0.001*
with a variety of pains with NRS equal or more than 5. He
divided them into 2 groups of 45 subjects and compared
the analgesic effect and complications caused by 0.3 mg/kg
of ketamine and 0.1 mg/kg of morphine 120 minutes after
injection. In this study, LDK was effective in the short term
on pain relief similar to morphine. Hence, the rate of com-
plications in the ketamine group was significantly higher
than the morphine group.
Miller et al. (20) performed a study on 45 patients (21
patients received 0.1 mg/kg morphine and 24 patients re-
ceived 0.3 mg/kg ketamine). In this study, recipients of
morphine in a time of 100 minutes after injection experi-
enced a slowly reduced pain. The LDK Group, during the
first 5 minutes, had the greatest pain reduction; 15 minutes
later the effect of ketamine was reduced. Finally, it can be
concluded that LDK is not superior to morphine as an anal-
gesic.
Several studies have also examined the safety and anal-
gesic effects of ketamine in pre-hospital. Jennings et al.
(21) in a systematic review on the effects of ketamine on re-
ducing pain in pre-hospital trauma patients demonstrated
that ketamine, as a safe and effective analgesic, can be uti-
lized in the pre-hospital.
In a non-randomized retrospective cohort study car-
ried out in pre-hospitals in the war zone of Iraq, the anal-
gesic effect of ketamine, at a dose of 0.2 mg/kg, was com-
pared with pentazocine at 0.4 mg/kg and placebo. The
authors concluded that intravenous ketamine improved
blood pressure and is a good analgesic for low-resource set-
ting (22).
Lak et al. used 0.5 mg/kg followed by a continuous in-
fusion (in a rate of 2 µg/kg/min for the first 24 hours and 1
µg/kg/min for the next 24 hours) of ketamine, in a study on
50 post-nephrectomy cases; they showed a decreased need
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Table 3. Adverse Effects
Number (%) Group P Value
Ketamine Morphine
Nausea 24 (16) 26 (17) 0.51
Flushing 0 54 (36) < 0.001*
Dizziness 51 (34) 48 (32) 0.83
Mood changes 6 (4) 4 (2) 0.24
O2 saturation < 90% 6 (4) 27 (18) 0.02
*
Hypotension, (SBP < 90mmHg) 0 0 -
to analgesics using ketamine compared to placebo (23).
Intravenous, subcutaneous, and spray forms of ketamine
were shown to decrease children’s pain and the need to
analgesics, effectively, in 2 studies on post-tonsillectomy
cases (24, 25).
The present study suggests that the analgesic effect
of LDK is similar to morphine 15 minutes after injection.
In the next few minutes, LDK effect in reducing pain was
weakened unlike the morphine group. Previous stud-
ies mentioned above also demonstrated the effect of ke-
tamine in the first few minutes after injection. A point
of interest in our study was that complications caused in
the LDK group were less than the morphine group. Flush-
ing and drop in O2 saturation below 90% in the morphine
group was significantly higher. On the other hand, the LDK
group required additional tranquilizers; in addition, recip-
ients of morphine were more satisfied with analgesia. This
points show the need for further studies with larger sam-
ple sizes and different doses of ketamine.
5.1. Limitations
Some side effects such as nystagmus may interfere with
blinding the study. The recipients were followed for 60
minutes. Increasing patients’ follow-up time provided the
possibility of obtaining valuable results.
5.2. Conclusion
The results of this study suggest that low dose ke-
tamine, at a dose of 0.2 mg/kg in early minutes, leads to
significant reduction of pain when compared to that of in-
travenous morphine. It also created fewer complications
than morphine.
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